Navigation Links
UNC study supports role of circadian clock in response to chemotherapy
Date:1/13/2009

CHAPEL HILL For years, research has hinted that the time of day that cancer patients receive chemotherapy can impact their chances of survival. But the lack of a clear scientific explanation for this finding has kept clinicians from considering timing as a factor in treatment.

Now, a new study from the University of North Carolina at Chapel Hill has suggested that treatment is most effective at certain times of day because that is when a particular enzyme system one that can reverse the actions of chemotherapeutic drugs is at its lowest levels in the body.

The study, performed in mice, could also have implications for the prevention of new cancers.

The enzyme system implicated called nucleotide excision repair repairs many types of DNA damage that come not just from chemotherapy but also from the ultraviolet rays of the sun. Thus, by understanding the cyclical nature of this system, physicians may be able to pinpoint when it is most crucial for people to protect themselves from sun exposure to minimize their risk of skin cancer.

"Timing is everything, and here we have molecular data showing why this is especially true with regard to cancer," said senior study author Aziz Sancar, M.D., Ph.D., a member of the UNC Lineberger Comprehensive Cancer Center and Sarah Graham Kenan professor of biochemistry and biophysics in the UNC School of Medicine. Sancar is also a member of the National Academy of Sciences and the Turkish Academy of Sciences. "By hitting cancer cells with chemo at a time when their ability to repair themselves is minimal, you should be able to maximize effectiveness and minimize side effects of treatment."

The study, set to appear this week in the online early edition of the Proceedings of the National Academy of Sciences, provides the first solid evidence that the daily oscillations of the cell's repair machinery can affect the potency of cancer drugs.

The primary driver of this os
'/>"/>

Contact: Les Lang
llang@med.unc.edu
919-966-9366
University of North Carolina School of Medicine
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Medical study shows epidurals and spinal anesthetics are safer than previously reported
2. InterMune Reports Results from Triple Combination Study of ITMN-191
3. LegalView Reports Traumatic Brain Injury Study Concluding Spirituality Increases Following Brain Damage
4. Lupus is a Significant Cost to Employers, According to Thomson Reuters Study
5. Penn study: Chances of surviving cardiac arrest depend on where patients are treated
6. Study: Fluoridation Benefits Doubtful
7. U.S. Preventive Medicine: Chronic Disease Study Demonstrates Need for Focus on Primary and Secondary Prevention
8. Study Finds More Effective Treatment for Pneumonia Following Influenza
9. Study finds more effective treatment for pneumonia following influenza
10. WorldHeart Submits IDE Application for a Pivotal Bridge-to-Transplant Study of the Levacor(TM) VAD
11. Government at all Levels Will Continue to Spend on Essential Services and Invest in the Future, According to Onvia Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... (PRWEB) January 22, 2015 A ... Sports Medicine flagship journal Medicine & Science in ... before exercise may help reduce gastrointestinal (GI) problems ... , Participants in the double-blind, placebo-controlled study ...
(Date:1/22/2015)... 2015 IsoComforter, Inc. has introduced the most ... IsoTube design to treat specific body parts and muscle groups. ... and easy to use patented cold therapy machine with the ... orthopedic and muscle injuries. IsoComforter has become the industry ...
(Date:1/22/2015)... January 22, 2015 EBSCO Information Services ... are expanding their relationship in an effort to further promote ... world. While EBSCO has long made AMA journals available via ... agent for The JAMA Network. , Long known ...
(Date:1/22/2015)... Compare-autoinsurance.org has released a new blog post presenting a list ... policy . , Some types of vehicles cannot be covered ... released blog post to see if their vehicle qualifies for auto ... some of the cars that cannot be covered by a plan. ...
(Date:1/22/2015)... 22, 2015 State Forestry Institute of ... system with support from GEOSYSTEMS, a dedicated Hexagon Geospatial ... will leverage Hexagon Geospatial’s ERDAS APOLLO for ... well as point clouds and documents. This effort will ...
Breaking Medicine News(10 mins):Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 3
... to normalize up, to 600,000 internally displaced residents of Baghdad into ... ... 6 Dr. Said Hakki, president,of the Iraqi Red Crescent Organization ... discuss the organization,s,Neighborhood Reconstruction Program (NRP) to immediately assist up to,600,000 ...
... Some of the UKs leading experts in location technologies ... hospitals are already improving the efficiency and quality of ... between hardware and software applications, and a lack of ... NHS is not benefiting as much as it could. ...
... GREAT RIVER, N.Y., May 6 VirtualCDO acted ... the sale of the company to Lawson,Software (St. ... management,software and services, assisted healthcare, hospitality and government,service ... enterprise,software and enterprise management services to some 4,000 ...
... Patients, Safety,Concerns, But Lack Confidence About Best Ways ... As patient safety,incidents in America,s hospitals continue ... hospital CEOs feel strongly confident about practices in,place ... the VHA Foundation,today formally launched the "Health Care ...
... Institute (HMRI) and Xstrata Coal will today announce a significant ... asthma in the Hunter and beyond. , Xstrata Coal has ... a newly recognised type of asthma which accounts for 50 ... Asthma Research Fellow, Dr Katie Baines from the University of ...
... experience can be deadly, say authors of a new survey ... often underestimate their level of driving experience, putting them at ... , And while many teens recognize that drinking and driving ... distraction posed by having friends in the car. , "We ...
Cached Medicine News:Health News:Dr. Said Hakki, President of Iraqi Red Crescent Organization, in the United States and Available for Interviews May 12-16 2Health News:Dr. Said Hakki, President of Iraqi Red Crescent Organization, in the United States and Available for Interviews May 12-16 3Health News:Location! Location! Location technologies are improving NHS care 2Health News:VirtualCDO Acts as M&A Advisor in Sale of VasTech to Lawson Software 2Health News:VHA Foundation Launches National CEO Patient SafetyNetwork, Starting From the Top to Make Patients Safer 2Health News:VHA Foundation Launches National CEO Patient SafetyNetwork, Starting From the Top to Make Patients Safer 3Health News:Many Teen Drivers Don't Think They're Inexperienced 2Health News:Many Teen Drivers Don't Think They're Inexperienced 3
(Date:1/23/2015)... N.Y. , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. ... its Phase I trial of Lixte,s lead compound, LB‑100, is ... John S. Kovach , M.D., the founder ... planned to be completed at a single site. Accrual of ...
(Date:1/23/2015)... Africa , Jan. 23, 2015   Leatt Corporation ... personal protective equipment for all forms of sports, including ... Leatt-Brace® neck brace, announced today that the UISP Lega ... now requires all riders to wear a neck brace ...
(Date:1/23/2015)...  Mallinckrodt plc (NYSE: MNK ) announced today ... repurchase program. The open-ended authorization permits the company to ... shares. "Funding additional initiatives and seeking ... continue to pursue a range of focused growth strategies," ...
Breaking Medicine Technology:Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 3Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4
... Shire plc (LSE: SHP,Nasdaq: SHPGY), the global ... scientific meeting findings from analyses of pivotal ... compound is an,investigational once-daily medication, which is ... of Attention Deficit Hyperactivity Disorder,(ADHD). The data ...
... and 2 Data Expected at ASCO in June ... Poniard,Pharmaceuticals, Inc. (Nasdaq: PARD ), a ... has completed patient enrollment in,its Phase 2 clinical ... of metastatic colorectal cancer (CRC). Early,data from this ...
Cached Medicine Technology:Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 2Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 3Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 4Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 5Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 6Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer 2Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer 3Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer 4
...
...
...
Rhoton Curettes, titanium, length 191 mm, straight....
Medicine Products: